Evidence map›Paper›PMID 37179539›Full record

ArticleJAAD international2023

Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient management.

Jemima E Mellerio, Dimitra Kiritsi, M Peter Marinkovich, Natividad Romero Haro, Kellie Badger, Meena Arora, Marc A Dziasko, Mansi Vithlani, Anna E Martinez

Abstract read
In one paragraph

Article in JAAD international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jemima E MellerioSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Dimitra KiritsiDepartment of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
M Peter MarinkovichDepartment of Dermatology, Stanford University School of Medicine, Stanford, California.
Natividad Romero HaroDepartment of Healthcare, DEBRA, Marbella, Spain.
Kellie BadgerPhoenix Children's Hospital, Phoenix, Arizona.
Meena AroraAmryt Pharma plc, London, UK.
Marc A DziaskoDolon Ltd, London, UK.
Mansi VithlaniDolon Ltd, London, UK.
Anna E MartinezDepartment of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The pathophysiological processes underlying the phenotypic spectrum of severe forms of epidermolysis bullosa (EB) are complex and poorly understood. Objective: To use burden mapping to explore relationships between primary pathomechanisms and secondary clinical manifestations in severe forms of EB (junctional and dystrophic EB [JEB/DEB]) and highlight strengths and weaknesses in evidence regarding the contribution of different pathways. Methods: Literature searches were performed to identify evidence regarding the pathophysiological and clinical aspects of JEB/DEB. Identified publications and clinical experience were used to construct burden maps to visually communicate plausible connections and their relative importance by subtype. Results: Our findings suggest that most of the clinical consequences of JEB/DEB may result from an abnormal state and/or faulty skin remodeling driven by a vicious cycle of delayed wound healing, predominantly mediated through inflammation. The quantity and quality of evidence varies by individual manifestations and disease subtype. Limitations: The burden maps are provisional hypotheses requiring further validation and are limited by the published evidence base and subjectivity in clinical opinion. Conclusions: Delayed wound healing appears to be a key driver of the burden of JEB/DEB. Further studies are warranted to understand the role of inflammatory mediators and accelerated wound healing in patient management.

Indexed as

blisteringclinical manifestationsdisease burden mappingepidermolysis bullosapathophysiologywound healing

Identifiers

PMID37179539
PMCPMC10173168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.